Logo

BrightInsight Launches a CE-Marked Dosing Calculator for Emicizumab to Treat Patients with Hemophilia A

Share this

BrightInsight Launches a CE-Marked Dosing Calculator for Emicizumab to Treat Patients with Hemophilia A

Shots:

  • BrightInsight’s CE-marked dosing calculator enables health care professionals to determine the correct dosage & number of vials based on recommended dosage for the treatment of Hemophilia A with its development & distribution sponsored by Roche
  • The calculator helps in determining the correct loading and maintenance dose of emicizumab based on BrightInsight’s Internet of Things platform providing digital health solutions
  • The dosing Calculator is built under its ISO 13485:2016 Certified QMS and is a CE marked SaMD- used by healthcare professionals in Europe

Ref: Business Wire | Image: Chicago Tribune

Click here to­ read the full press release 

Senior Editor

This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com

Share this article on WhatsApp, LinkedIn and Twitter

Join the PharmaShots family of 12000+ subscribers

I accept the Terms and Conditions